Summary:
A Phase 3, Multicenter, Randomized, Double-blind Trial of Brexpiprazole as Combination Therapy with Sertraline in the Treatment of Adults with Post-traumatic Stress Disorder
Qualified Participants Must:
• 18 to 65
•
PTSD Symptoms at least 6 months
•
Traumatic event was not greater than 9 years ago or before age 16
•
No traumatic events in past 3 months
•
Not receiving disability payments due to PTSD
•
Not in compensation litigation
Qualified Participants May Receive:
Investigational medications and compensation for time and travel